STIFEL FINANCIAL CORP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$11,000
-38.9%
13,000
-40.9%
0.00%
Q1 2020$18,000
-21.7%
22,000
-5.6%
0.00%
Q4 2019$23,000
+27.8%
23,302
+28.5%
0.00%
Q2 2019$18,00018,1310.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders